A Study of De-immunized DI-Leu16-IL2 Administered Subcutaneously in Participants With B-cell NHL

Clinical trial NCT01874288 · TERMINATED

Trial details

NCT number: NCT01874288
Sponsor: Alopexx Oncology, LLC
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B-cell Non-Hodgkin Lymphoma

Start date: 2013-11-25
Primary completion: 2014-01-27
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.